Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH RecommandationsPar SFTH5 mars 2024
The risk of venous thromboembolism in early pregnancy loss: Review of the literature and current guidelines and the need for guidance – Communication from the SSC on Women’s Health Issues for thrombosis and haemostasis RecommandationsPar SFTH5 mars 2024
Recommendations for clinical laboratory testing for protein C deficiency SSC plasma coagulation inhibitors » RecommandationsPar SFTH5 mars 2024
Recommendations for clinical laboratory testing for antithrombin deficiency SSC plasma coagulation inhibitors » RecommandationsPar SFTH5 mars 2024
Lupus anticoagulant detection in anticoagulated patients. Guidance from the SSC lupus anticoagulant/antiphospholipid antibodies RecommandationsPar SFTH5 mars 2024
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the SSC ISTH RecommandationsPar SFTH5 mars 2024
Guidance from the SSC for lupus anticoagulant/antiphospholipid antibodies RecommandationsPar SFTH5 mars 2024
Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH RecommandationsPar SFTH5 mars 2024
Recommendations for clinical laboratory testing for protein S deficiency SSC plasma coagulation inhibitors RecommandationsPar SFTH5 mars 2024
Recommendations for the measurement of thrombin generation SSC Lupus Anticoagulant RecommandationsPar SFTH5 mars 2024